Purpose This article highlights one health system's response to the market influx of biosimilars with the establishment of a process for formulary review and selection of preferred agents and support for therapeutic interchanges.Summary Through assessment of available literature, insurance payor cov...
No comments yet
Be the first to share your thoughts!